Urogen Pharma (NASDAQ:URGN) Stock: Insider Chris Degnan Sells 2,202 Shares
MarketBeat
Urogen Pharma (NASDAQ:URGN - Get Free Report) CFO Chris Degnan sold 2,202 shares of the business's stock in a transaction that occurred on Thursday, October 8th. The stock was sold at an average price of $36.69, for a total transaction of $80,791.38. Following the completion of the transaction, the chief financial officer owned 4,561 shares of the company's stock, valued at $167,343.09. This trade represents a 32.56% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.
NASDAQ:URGN